JonesResearch analyst Justin Walsh initiated coverage of Serina Therapeutics (SER) with a Buy rating and $11 price target. Serina is a drug ...
Mar. 9, 2025 — A recently launched Phase 1 clinical trial is examining the safety and feasibility of a groundbreaking treatment approach for Parkinson's disease in which a patient's stem cells ...
Mar. 9, 2025 — A recently launched Phase 1 clinical trial is examining the safety and feasibility of a groundbreaking treatment approach for Parkinson's disease in which a patient's stem cells ...
Parkinson's disease presents with many symptoms, over 40 in fact, including the well-known tremor in the arms and hands. The progression and sequence of these symptoms differ among the ...
Objectives: This study aimed to identify, measure and evaluate expected costs of innovative palonosetron-based antiemetic therapy versus ondansetron-based treatment, the ultimate aim being to ...
Disease prevention is a procedure through which individuals, particularly those with risk factors for a disease, are treated in order to prevent a disease from occurring. Treatment normally begins ...
Penmenvy (meningococcal Groups A, B, C, W, and Y vaccine) Meningococcal vaccine For active immunization to prevent invasive disease caused by Neisseria meningitidis serogroups A, B, C, W, and Y in ...
Parkinson's disease (PD) is not a fatal disease, but it can indirectly reduce life expectancy, most often due to complications like aspiration pneumonia or falls. Many factors can influence survival ...
Digital Biomarkers for Parkinson's Disease Toolbox.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results